25 results
424B5
VANI
Vivani Medical Inc
5 Mar 24
Prospectus supplement for primary offering
11:31am
pandemic and macroeconomic factors that could impact our business, such as supply chain and inflationary pressures and the effects of the Russian … , interruptions or other adverse
effects to clinical trials and patient enrollment; delays in regulatory review; manufacturing and supply chain interruptions
DEFR14A
VANI
Vivani Medical Inc
1 May 23
Revised proxy
4:49pm
, quality systems, manufacturing, supply chain, product development, formulation, and IT. From 2009 to 2011, Mr. Le was the Chief Operating Officer
DEFM14A
afwbd e8jmwrox
24 Jun 22
Proxy related to merger
4:44pm
424B3
4npbv54 sh
24 Jun 22
Prospectus supplement
4:38pm
S-4/A
ji0 2h1nmtjw0
16 Jun 22
Registration of securities issued in business combination transactions (amended)
5:23pm
S-4
194kv4
13 May 22
Registration of securities issued in business combination transactions
5:10pm
424B5
e1s n40sbog
23 Jun 21
Prospectus supplement for primary offering
12:26pm
424B5
u4fukf0
22 Jun 21
Prospectus supplement for primary offering
5:23pm
424B3
bvc5 hfhpxkqx3sec
28 Apr 21
Prospectus supplement
9:49pm
8-K
EX-2.1
10khy
6 Jan 21
Pixium Vision and Second Sight Medical Products announce business combination, creating a global leader in the sight restoration market
6:14am